Waters Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Waters Corporation - overview
Location
-, MA, US
Primary Industry
Medical Devices & Equipment
About
Waters Corporation is a global leader in analytical instrumentation, providing innovative solutions in laboratory science, specifically through cutting-edge liquid chromatography and mass spectrometry technologies. Waters Corporation specializes in laboratory instruments and software solutions for the analytical sciences. Founded by Neville Waters, the company was floated on the NYSE in 1995. The headquarters is located in Milford, US.
Udit Batra currently serves as CEO. The company has completed 2 deals since its inception, with its most recent deal occurring in June 1995. Waters Corporation specializes in developing laboratory instruments, consumables, and software solutions for the analytical sciences. Key product offerings include advanced liquid chromatography (LC) and mass spectrometry (MS) technologies, catering to industries such as biopharma, food and beverage, clinical research, and environmental testing.
Their technologies address critical analytical challenges, including PFAS analysis, serving clients from academic institutions to pharmaceutical companies across North America, Europe, and Asia Pacific. Waters Corporation operates primarily through B2B transactions, generating revenue from the sale of instruments, consumables, and software solutions. In the most recent year, 2024, the company reported a revenue of USD 1. 84 bn and an EBITDA of USD 1.
02 bn. Their offerings include subscription services for software solutions, which provide users with ongoing access to updates and support. Waters Corporation is focused on expanding its product portfolio and entering new markets. The company aims to launch several new products in the coming years, with specific designs targeting enhanced analytical performance.
Plans are in place for expansion into emerging markets in Asia and Europe by 2025. The funding from its most recent NYSE flotation will be utilized to support these initiatives and bolster development efforts across these regions.
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment
Website
www.waters.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Waters Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPO | Completed | Waters Corporation | - | ||||||||
| Buyout | Completed | Waters Corporation | - |
Displaying 1 - 2 of 2

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.